2021
DOI: 10.22541/au.161426148.87135998/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

2q13 microdeletion syndrome: report on a newborn with additional features expanding the phenotype

Abstract: In this paper we describe an additional newborn patient with craniofacial dysmorphisms, congenital heart disease, hypotonia and a 2q13 deletion of 1.7 Mb, whose clinical and genomic findings are consistent with the diagnosis of 2q13 microdeletion syndrome.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…We strongly recommend glycemic and hormone screening of CES patients, to prevent potential life-threatening conditions. A multidisciplinary (auxological/endocrinological, neurodevelopmental, surgical, ophthalmological, audiological, cardiological, orthopedic) management and longitudinal follow-up [21][22][23][24][25][26][27] must be guaranteed to affected subjects. The latter should be oriented to a prompt recognizing of complications and/or associated anomalies [28][29][30][31][32][33][34], allowing practitioners to thus lower mortality rates and short-and long-term adverse outcomes [35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…We strongly recommend glycemic and hormone screening of CES patients, to prevent potential life-threatening conditions. A multidisciplinary (auxological/endocrinological, neurodevelopmental, surgical, ophthalmological, audiological, cardiological, orthopedic) management and longitudinal follow-up [21][22][23][24][25][26][27] must be guaranteed to affected subjects. The latter should be oriented to a prompt recognizing of complications and/or associated anomalies [28][29][30][31][32][33][34], allowing practitioners to thus lower mortality rates and short-and long-term adverse outcomes [35][36][37].…”
Section: Discussionmentioning
confidence: 99%
“…The current database should be updated with the genomic and phenotypic findings of the present patient, in order to provide a better characterization of such a rare disease. Additional patients and the identification of new mutations will increase the knowledge on the molecular bases and the pathogenic mechanisms underlying OS-CS [20][21][22][23][24][25][26][27][28][29]. Neonatologists and pediatricians should rise such diagnostic suspicion in case of newborns/ infants with macrocephaly (even if relatively severe when compared to weight and length, as in our proposita), peculiar facial features and limbs anomalies.…”
Section: Discussionmentioning
confidence: 99%
“…In these cases, the suspicion of AEC syndrome must be promptly raised, and sequencing analysis of TP63 early performed as well. An individualized, multidisciplinary and long-term follow-up should be guaranteed to affected subjects and their families, aimed at identifying associated morbidities and preventing and/or lowering possible serious complications and adverse outcomes [ 25 27 ].…”
Section: Discussionmentioning
confidence: 99%